Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (year values)

2019 2020 2021 2022 2023   LTM ?
Debt/EBITDA 1.42 1.84 2.17 0.94 -0.94   11.2
Changes by years, y/y, % +13% +29% +18% -57% -200%    

Alnylam Pharmaceuticals. Debt/EBITDA

Alnylam Pharmaceuticals. Debt/EBITDA, changes, %

Alnylam Pharmaceuticals (ALNY) Debt/EBITDA US GAAP (quarter values)

2023Q3 2023Q4 2024Q1 2024Q2 2024Q3   LTM ?
Debt/EBITDA 2.97 -0.85 -2.00 0.67 11.2   11.2
Changes by years, y/y, % +136% -171% -292% -28% +278%    
Changes by quarters, q/q, % +219% -129% +134% -134% +1 571%    

Alnylam Pharmaceuticals. Debt/EBITDA

Alnylam Pharmaceuticals. Debt/EBITDA, changes, y/y, %

Alnylam Pharmaceuticals. Debt/EBITDA, changes, q/q, %